Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
|Articles|January 28, 2021
How to Keep Health Care Workers Safe While Administering the COVID-19 Vaccine
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how pharmacies and other health care setting can keep their employees and patients safe as they administer the COVID-19 vaccine.
Advertisement
Pharmacy Times® interviewed Rob LaHayne, the CEO of TouchCare, on how pharmacies and other health care setting can keep their employees and patients safe as they administer the coronavirus disease 2019 (COVID-19) vaccine.
For the full conversion, see the video above.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Advertisement
Advertisement